T +44 (0)1223 810 700
Translational, objective and validated. Gold standard cognitive testing products for researchers.
Accelerating safe and effective pharmaceutical development with increased chances of success.
Detecting cognitive impairment early to maximize the effect of treatments, improve wellbeing and save costs.
Cantab Connect Alzheimer’s provides touchscreen iPad assessment of patients with mild to moderate Alzheimer's disease enabling drug developers to measure the cognitive impact of potential new drug treatments accurately and consistently in each stage of clinical development.
18 May 2015
Memory survey - Dementia awareness week
12 May 2015
Biosimilars and drug safety